The agreement, which also includes a team of biotech executives, will see Bluebird Bio’s stockholders receive $3.00 per share ...

Blue Bird Corporation (BLBD) recently announced fiscal Q1 results, beating top and bottom-line expectations. While the ...

Gene therapy developer bluebird bio (NASDAQ:BLUE) announced Friday its plans to become a privately held biotech as part of an M&A agreement with private equity firms, Carlyle Group (NASDAQ:CG) and SK ...

A pair of investors will acquire bluebird bio in a deal worth only $29 million upfront after the gene therapy maker ran out ...

BLBD remains volatile despite strong earnings, federal funding uncertainties, and revised EV sales guidance. Explore more ...

Blue Bird Corporation is a compelling investment due to its focus on electric school buses and attractive stock valuation despite recent performance setbacks. Read more here.

MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, has appointed John Wyskiel to the position of President and CEO ...

KBC Group NV’s holdings in Blue Bird were worth $55,000 as of its most recent SEC filing. A number of other hedge funds have also recently bought and sold shares of BLBD.

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Blue Bird (BLBD – Research Report) and Alibaba (BABA ...

Its dedicated members volunteer thousands of hours of service to the clinic, the Blue Bird Resale Shop, and the group's other fund-raising activities. Since 1986, the Blue Bird Circle has provided ...